Knochenmarkstammzellen: New Perspectives in Oncology and Hematology
Stammzellen des Knochenmarks (BMSCs) have emerged as a promising frontier in oncology and hematology. Their unique regenerative and immunomodulatory properties offer novel therapeutic avenues for treating hematological malignancies, Gewebeschäden, und Immunstörungen. This article explores the latest advancements in BMSC research, highlighting their potential in disease management and tissue regeneration.














